Arcutis Biotherapeutics champions innovation that addresses real patient needs—solving the everyday medical dermatology challenges that significantly impact patients and their families. With a passion for understanding what really matters to patients and healthcare providers, Arcutis leverages extensive dermatology development expertise to meaningfully advance the treatment of immune-mediated skin diseases.
This expertise, along with Arcutis’ focus on biologically validated targets and its unique product development platform, prepares the company to tackle topical treatment innovation. Founded in 2016 by a leadership team with deep dermatology and commercialization experience—including 50+ FDA-approved products among them—Arcutis features four trained dermatologists on staff.